- the
integrated stress response pathway. Arnold, F. J.; Nguyen, A. D.;
Bedlack, R. S.; Bennett, C. L.; La Spada, A. R. (1
August 2023). "Intercellular...
- 1719–1725. doi:10.1212/WNL.0000000000000951. PMC 4239834. PMID 25298304.
Bedlack RS,
Vaughan T,
Wicks P,
Heywood J,
Sinani E,
Selsov R, et al. (March 2016)...
- 102 (17_supplement_1): 3593. doi:10.1212/WNL.0000000000205241. Li X,
Bedlack R (June 2024). "Evaluating
emerging drugs in
phase II & III for the treatment...
- 1212/WNL.0000000000004209. PMC 5562960. PMID 28701493.
Pastula DM,
Moore DH,
Bedlack RS (December 2012). "Creatine for
amyotrophic lateral sclerosis/motor neuron...
- doi:10.4103/0301-4738.145987. PMC 4278125. PMID 25449931.
Scherer K,
Bedlack RS,
Simel DL (April 2005). "Does this
patient have
myasthenia gravis?"...
-
explanation for
these improvements was the use of lunasin, Dr.
Richard Bedlack of the Duke ALS
Clinic decided to
perform a
clinical trial.
Fifty people...
- Steve; McIlduff,
Courtney E.; Paganoni, Sabrina; Maragakis,
Nicholas J.;
Bedlack, Richard; Goyal,
Namita A.; Rutkove,
Seward B.; Lange, Dale J.; Rivner...
-
November 2016.
Retrieved 6
November 2016. Pastula,
Daniel M.; Moore, Dan H.;
Bedlack,
Richard S. (12
December 2012). "Creatine for
amyotrophic lateral sclerosis/motor...
-
drugs they were
taking were working. A 2016
collaboration with Dr Rick
Bedlack of the Duke ALS
Clinic aims to
overcome some of the
burden of traditional...
- PMID 16289867. S2CID 22794616.
Cudkowicz ME,
Andres PL,
Macdonald SA,
Bedlack RS,
Choudry R,
Brown RH,
Zhang H,
Schoenfeld DA,
Shefner J,
Matson S, Matson...
